Synthetic approaches to the 2012 new drugs

被引：38
|
作者：
Ding, Hong X. [1 ]
Leverett, Carolyn A. [2 ]
Kyne, Robert E., Jr. [2 ]
Liu, Kevin K. -C. [3 ]
Sakya, Subas M. [4 ]
Flick, Andrew C. [2 ]
O'Donnell, Christopher J. [2 ]
机构：
[1] PharmaPhase Co Ltd, Beijing 100193, Peoples R China
[2] Pfizer Worldwide Res & Dev, Groton Labs, Groton, CT 06340 USA
[3] Lilly China Res & Dev Ctr, Shanghai 201203, Peoples R China
[4] BioDuro Co Ltd, Shanghai 200131, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2014年 / 22卷 / 07期
关键词：
Synthesis; New drug molecules; New chemical entities; Medicine; Therapeutic agents; CHRONIC MYELOID-LEUKEMIA; ANTIINFLAMMATORY AGENT 3-FORMYLAMINO-7-METHYLSULFONYLAMINO-6-PHENOXY-4H-1-BENZOPYRAN-4-ONE; DIHYDROOROTATE DEHYDROGENASE; ANTITUMOR ALKALOIDS; PASIREOTIDE SOM230; INGENOL ESTERS; IN-VITRO; INHIBITOR; POTENT; DISCOVERY;
D O I：
10.1016/j.bmc.2014.02.017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
New drugs introduced to the market every year represent a privileged structure for a particular biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the synthesis of twenty-six NCEs that were launched or approved worldwide in 2012 and two additional drugs which were launched at the end of 2011. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2005 / 2032
页数：28
相关论文
共 50 条
  • [1] Synthetic Approaches to the 2007 New Drugs
    Liu, Kevin K. -C.
    Sakya, Subas M.
    O'Donnell, Christopher J.
    Li, Jin
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (14) : 1526 - 1548
  • [2] Synthetic approaches to the 2004 new drugs
    Li, J
    Liu, KKC
    Sakya, S
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) : 1133 - 1144
  • [3] Synthetic approaches to the 2011 new drugs
    Ding, Hong X.
    Liu, Kevin K. -C.
    Sakya, Subas M.
    Flick, Andrew C.
    O'Donnell, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (11) : 2795 - 2825
  • [4] Synthetic approaches to the 2006 new drugs
    Liu, Kevin K. -C.
    Sakya, Subas A.
    Li, Jin
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (12) : 1255 - 1269
  • [5] Synthetic approaches to the 2009 new drugs
    Liu, Kevin K. -C.
    Sakya, Subas M.
    O'Donnell, Christopher J.
    Flick, Andrew C.
    Li, Jin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (03) : 1136 - 1154
  • [6] Synthetic approaches to the 2014 new drugs
    Flick, Andrew C.
    Ding, Hong X.
    Leverett, Carolyn A.
    Kyne, Robert E., Jr.
    Liu, Kevin K. -C.
    Fink, Sarah J.
    O'Donnell, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (09) : 1937 - 1980
  • [7] Synthetic approaches to the 2005 new drugs
    Sakya, Subas M.
    Li, Jin
    Liu, Kevin K. -C.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (04) : 429 - 450
  • [8] Synthetic approaches to the 2010 new drugs
    Liu, Kevin K. -C.
    Sakya, Subas M.
    O'Donnell, Christopher J.
    Flick, Andrew C.
    Ding, Hong X.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1155 - 1174
  • [9] Synthetic Approaches to the 2008 New Drugs
    Liu, Kevin K. -C.
    Sakya, Subas M.
    O'Donnell, Christopher J.
    Li, Jin
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (14) : 1655 - 1675
  • [10] Synthetic approaches to the 2003 new drugs
    Liu, KKC
    Li, J
    Sakya, S
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (10) : 1105 - 1125
12345